Categories AlphaGraphs, Earnings, Health Care

Vertex Pharmaceuticals reports 14% growth in Q1 revenue: Infographic

Vertex Pharmaceuticals (NASDAQ: VRTX) reported first-quarter 2021 financial results after the regular market hours on Thursday. The pharmaceutical firm reported Q1 revenue of $1.72 billion, up 14% year-over-year and above the Wall Street projection. Net income of $2.98 per share was also above the target that analysts had anticipated.

VRTX shares were down 0.4% immediately following the announcement. The stock has fallen 7% since the beginning of this year.

Vertex Pharma Q1 2021 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Vertex Pharmaceuticals Q1 earnings call transcript

Prior performance

Most Popular

Key metrics from Kroger’s (KR) Q3 2025 earnings results

The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical

Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights

Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or

HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results

Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top